During the past decade, CMed Rehabilitációs és Diagnosztikai Központ conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CMed Rehabilitációs és Diagnosztikai Központ" are "Rheumatoid Arthritis" (2 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "CMed Rehabilitációs és Diagnosztikai Központ" in a lesser frequency.

Most popular intervention types in "CMed Rehabilitációs és Diagnosztikai Központ" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABX464" (1 trials), "ABX464 100mg" (1 trials), "ABX464 50mg" (1 trials), "BMS-986165 Dose A" (1 trials) and "BMS-986165 Dose B" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMed Rehabilitációs és Diagnosztikai Központ" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CMed Rehabilitációs és Diagnosztikai Központ". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CMed Rehabilitációs és Diagnosztikai Központ, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMed Rehabilitációs és Diagnosztikai Központ, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".